News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Stephen V Liu: ESMO23 – Dr. Solange Peters presents the PERLA randomized phase II study
Photo of Solange Peters taken from Stephen V Liu/Twitter
Oct 24, 2023, 13:45

Stephen V Liu: ESMO23 – Dr. Solange Peters presents the PERLA randomized phase II study

Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown University, on X/Twitter:

“ESMO23 – Dr. Solange Peters presents the PERLA randomized phase II study comparing two PD-1 inhibitors in NSCLC. Dostarlimab + chemotherapy versus pembrolizumab + chemotherapy. Some differences in dostarlimab binding – will that translate to an OS difference?”

Stephen V Liu: ESMO23 - Dr. Solange Peters presents the PERLA randomized phase II study

Source: Stephen V Liu/Twitter

cancer Dostarlimab ESMO OncoDaily Oncology pembrolizumab Solange Peters Stephen V Liu
Special Coverage
Blog
Mar 31, 2025, 20:43
Akhil Santhosh: Pembrolizumab and lenvatinib show promise in mesothelioma treatment
Blog
Mar 31, 2025, 20:25
Happy National Doctors’ Day - Mount Sinai Department of Medicine
Blog
Mar 31, 2025, 20:25
A rare glimpse inside doctors’ offices - Moffitt Cancer Center
Blog
Mar 31, 2025, 20:00
2 open positions in the IASLC team
Blog
Mar 31, 2025, 19:08
Predicting response to neoadjuvant chemotherapy in MIBC via interpretable multimodal deep learning
Blog
Mar 31, 2025, 19:01
Colorectal cancer affects all ages: learn your risks - Digestive Cancers Europe
Blog
Mar 31, 2025, 18:51
Insights from GUtrends25 on Urothelial Cancer Treatment by Tom Powles
Blog
Mar 31, 2025, 18:40
Celebrating National Doctors Day - Dolphins Cancer Challenge
Blog
Mar 31, 2025, 18:40
Serre-Beinier Veronique: Key Insights from ELCC 2025
Blog
Mar 31, 2025, 18:35
Binay Shah: Excited to break down barriers and bring quality care to those who need it most
Blog
Mar 31, 2025, 18:27
Bernard A. Fox: UbiVac Seeks Support and Partners to Bring DPV-001 Immunotherapy to Pediatric Cancer Trials
Career
Mar 31, 2025, 18:22
Maryam Yazdy has been appointed as the Senior Medical Director of Clinical Development at BeiGene